| http://www.w3.org/ns/prov#value | - The Manhattan research facility is working with Hemispherx Biopharma, a biopharmaceutical company, based in Philadelphia, to examine the potential of the drug Ampligen, as a treatment for CFS.Worldwide, 17 million people suffer from the syndrome, including at least one million Americans, according to the New York Times.For more information log onto www.enlander.com.
|
